# Rockwell Medical, Inc.: filings

RMTI · Nasdaq · CIK 1041024 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rmti.md) · [Financials](/companies/rmti/financials.md) · [Filings](/companies/rmti/filings.md) · [Insiders](/companies/rmti/insiders.md)

## Reports and events: 379 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 348, 8-K 244, 10-Q 53, 3 34, SC 13D/A 34, 4/A 32, DFAN14A 27, DEFA14A 25, SC 13G/A 20, UPLOAD 20, 10-K 18, 424B5 18, 144 17, CORRESP 17, DEF 14A 17, S-8 14, SCHEDULE 13G/A 13, SC 13G 12, ARS 11, EFFECT 11, S-3 10, 424B3 7, 8-K/A 7, CT ORDER 7, PRE 14A 6, 10-K/A 3, 3/A 2, D 2, DEFC14A 2, NT 10-K 2, PREC14A 2, PRRN14A 2, S-3/A 2, SCHEDULE 13G 2, 10-Q/A 1, 8-A12G/A 1, FWP 1, NT 10-Q 1, PRER14A 1, S-1 1, S-3MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 11:27 ET | [8-K](/filings/0001628280-26-056470.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-056470 |
| 2026-08-13 | 10:59 ET | [10-Q](/filings/0001628280-26-056461.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056461 |
| 2026-08-13 | 10:14 ET | [8-K](/filings/0001628280-26-056454.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056454 |
| 2026-07-20 | 10:22 ET | [8-K](/filings/0001628280-26-048752.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-048752 |
| 2026-06-29 | 10:17 ET | [8-K](/filings/0001628280-26-045866.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-26-045866 |
| 2026-06-15 | 20:27 ET | [8-K](/filings/0001628280-26-043210.md) | 5.07 Shareholder vote results | 0001628280-26-043210 |
| 2026-05-08 | 21:00 ET | [8-K](/filings/0001628280-26-032987.md) | 3.01 Delisting notice | 0001628280-26-032987 |
| 2026-05-07 | 11:14 ET | [8-K](/filings/0001628280-26-031680.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031680 |
| 2026-05-07 | 10:59 ET | [10-Q](/filings/0001628280-26-031663.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031663 |
| 2026-05-07 | 10:16 ET | [8-K](/filings/0001628280-26-031629.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031629 |
| 2026-04-30 | 10:59 ET | [DEF 14A](/filings/0001628280-26-028571.md) | Proxy statement, period 2026-04-30 | 0001628280-26-028571 |
| 2026-03-26 | 11:30 ET | [8-K](/filings/0001628280-26-021195.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-021195 |
| 2026-03-26 | 11:01 ET | [10-K](/filings/0001628280-26-021186.md) | Annual report, period 2025-12-31 | 0001628280-26-021186 |
| 2026-03-26 | 10:10 ET | [8-K](/filings/0001628280-26-021176.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-021176 |
| 2026-01-20 | 11:32 ET | [8-K](/filings/0001628280-26-002478.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-002478 |
| 2026-01-05 | 11:33 ET | [8-K](/filings/0001628280-26-000221.md) | 8.01 Other events | 0001628280-26-000221 |
| 2025-11-18 | 12:30 ET | [8-K](/filings/0001104659-25-113452.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-113452 |
| 2025-11-12 | 12:21 ET | [8-K](/filings/0001628280-25-051311.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-051311 |
| 2025-11-12 | 12:05 ET | [10-Q](/filings/0001628280-25-051290.md) | Quarterly report, period 2025-09-30 | 0001628280-25-051290 |
| 2025-11-12 | 11:11 ET | [8-K](/filings/0001628280-25-051267.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-051267 |
| 2025-09-29 | 20:32 ET | [8-K](/filings/0001104659-25-094524.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-094524 |
| 2025-08-14 | 11:05 ET | [10-Q](/filings/0001041024-25-000011.md) | Quarterly report, period 2025-06-30 | 0001041024-25-000011 |
| 2025-08-14 | 10:05 ET | [8-K](/filings/0001041024-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001041024-25-000009 |
| 2025-05-20 | 20:13 ET | [8-K](/filings/0001104659-25-050997.md) | 5.07 Shareholder vote results | 0001104659-25-050997 |
| 2025-05-12 | 11:21 ET | [8-K](/filings/0001628280-25-024444.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-024444 |
| 2025-05-12 | 11:00 ET | [10-Q](/filings/0001628280-25-024434.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024434 |
| 2025-05-12 | 10:18 ET | [8-K](/filings/0001104659-25-046957.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-046957 |
| 2025-04-14 | 10:30 ET | [DEF 14A](/filings/0001140361-25-013599.md) | Proxy statement, period 2025-05-20 | 0001140361-25-013599 |
| 2025-03-20 | 13:13 ET | [8-K](/filings/0001628280-25-014017.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-014017 |
| 2025-03-20 | 11:01 ET | [10-K](/filings/0001628280-25-013983.md) | Annual report, period 2024-12-31 | 0001628280-25-013983 |
| 2025-03-20 | 10:15 ET | [8-K](/filings/0001104659-25-025782.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-025782 |
| 2024-12-12 | 21:58 ET | [8-K](/filings/0001104659-24-128064.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-128064 |
| 2024-11-13 | 16:41 ET | [8-K](/filings/0001104659-24-117447.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-117447 |
| 2024-11-12 | 12:10 ET | [10-Q](/filings/0001628280-24-046839.md) | Quarterly report, period 2024-09-30 | 0001628280-24-046839 |
| 2024-11-12 | 12:03 ET | [8-K](/filings/0001628280-24-046835.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-046835 |
| 2024-11-12 | 11:09 ET | [8-K](/filings/0001628280-24-046792.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-046792 |
| 2024-08-08 | 20:51 ET | [8-K](/filings/0001628280-24-036211.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-036211 |
| 2024-08-08 | 11:00 ET | [10-Q](/filings/0001628280-24-035859.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035859 |
| 2024-08-08 | 10:14 ET | [8-K](/filings/0001628280-24-035830.md) | 9.01 Financial statements and exhibits | 0001628280-24-035830 |
| 2024-07-15 | 10:50 ET | [8-K](/filings/0001104659-24-079679.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-079679 |
| 2024-05-23 | 21:12 ET | [8-K](/filings/0001628280-24-025011.md) | 5.07 Shareholder vote results | 0001628280-24-025011 |
| 2024-05-14 | 21:10 ET | [8-K](/filings/0001628280-24-023287.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-023287 |
| 2024-05-14 | 11:11 ET | [10-Q](/filings/0001628280-24-023056.md) | Quarterly report, period 2024-03-31 | 0001628280-24-023056 |
| 2024-05-14 | 10:09 ET | [8-K](/filings/0001628280-24-023035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-023035 |
| 2024-04-15 | 20:05 ET | [DEF 14A](/filings/0001140361-24-019847.md) | Proxy statement, period 2024-05-21 | 0001140361-24-019847 |
| 2024-03-21 | 21:02 ET | [10-K](/filings/0001628280-24-012572.md) | Annual report, period 2023-12-31 | 0001628280-24-012572 |
| 2024-03-21 | 11:33 ET | [8-K](/filings/0001628280-24-012367.md) | 7.01 Regulation FD disclosure | 0001628280-24-012367 |
| 2024-03-21 | 10:15 ET | [8-K](/filings/0001104659-24-036897.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-036897 |
| 2024-01-09 | 22:51 ET | [8-K](/filings/0001628280-24-000874.md) | 7.01 Regulation FD disclosure | 0001628280-24-000874 |
| 2024-01-08 | 12:36 ET | [8-K](/filings/0001104659-24-002065.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-002065 |

Page 1 of 8. [Older](/companies/rmti/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.